Targeting the “sugar receptor” Siglec-10 for immune regulation
Targeting the glyco-immune checkpoint receptor Siglec-10 for immune modulation in cancer and autoimmune diseases
626 projects
Personalized mass spectrometry to improve diagnostics of hematological cancers
PRIME-TIME develops personalized minimal invasive diagnostics to predict, prevent and monitor disease-activity of hematological cancers.
Inhibiting the spread of mosquito-transmitted viruses
Radboudumc and TropIQ Health Sciences collaborate to find new ways to stop the spread of mosquito-borne viruses
Lighting the way out of skin fibrosis II
APOLLO-2 will deliver an innovative therapy to fight fibroblast-driven diseases like scleroderma.
Predict and Prevent Emerging Pathogen Threats
The integration of pan-genomics, population dynamics and clinical outcomes to elucidate emerging pathogen threats using machine learning.
Building a “mini-bone” to understand cancer spread in bone
OSCAR will faithfully mimic the anatomy and physiology of human bone to study bone metastasis
Patient outcome oriented care: an integral approach for patients with osteoarthritis
Using the ABCC-tool for patients with osteoarthritis; a new approach to guide care and selfmanagement
Development of artificial intelligence driven F-18-Fluoride PET/CT analysis of bone and joint pathology in spondyloarthritis and beyond
Development of automated PET/CT scan analysis for fast and accurate diagnosis and monitoring of spondyloarthritis
Proof of concept for peptide-based treatment against osteoarthritis
The next step in development and proof of concept for a peptide-based disease-modifying osteoarthritis drug candidate
Sugars to restore neonatal gut health
Non-digestible oligosaccharides as possible alternative treatment and/or prevention strategy for early life intestinal infections.